Håkan Tollefsen • 1972 • Charlottenlund • 10 roles • 12 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
O OBSIDO INVEST AS	Managing Director/CEO	40,000	-403,118	100 % directly
C CHAPMORE VENTURE AS	Managing Director/CEO	-	2,705,043	50 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
O OBSIDO INVEST AS	Chairman	40,000	-403,118	100 % directly
O OBSIDO GROUP AS	Contact Person	-	-3,961,678	55 % directly
C CHAPMORE VENTURE AS	Chairman	-	2,705,043	50 % directly
P PLAN INVESTOR AS	Chairman	-	681,486	50 % directly
A ACENTA AS	Chairman	7,446,547	900,644	24.16 % directly 4.93 % indirectly 19.23 %
B BREDEVEIEN BYGG AS	Board Member	10,181,987	49,263	15 % directly
X XQS HOLDING AS Closed	Board Member	-	5,830,798	2 % indirectly

Last update: Oct 1, 2024

Related industries

No related industries

Direct relationships5

KJ
Kristin Jenssen Hammervold1978
OBSIDO INVEST AS, CHAPMORE VENTURE AS, OBSIDO GROUP AS
CJ
Carsten Johansen1969
ACENTA AS
ET
Erik Tjelta1977
PLAN INVESTOR AS
AB
Arne Bredeveien1969
BREDEVEIEN BYGG AS
NR
Niels Ruben Ravnaas1979
XQS HOLDING AS

Shares owned by Håkan Tollefsen

Name	Share class	Total operating income	Total equity	Share
O OBSIDO INVEST AS	Ordinære aksjer	40,000	-403,118	100 % directly
O OBSIDO GROUP AS	Ordinære aksjer	0	-3,961,678	55 % directly
P PLAN INVESTOR AS	Ordinære aksjer	0	681,486	50 % directly
C CHAPMORE VENTURE AS	Ordinære aksjer	0	2,705,043	50 % directly
A AD-NOTAM NORGE AS Under liquidation		0	-471,072	35 % indirectly
G GF FINANCE HOLDING AS		0	485,185	20 % indirectly
B BREDEVEIEN BYGG AS	Ordinære aksjer	10,181,987	49,263	15 % directly
M MEDPRING AS Closed	Ordinære aksjer	0	-592,723	12.53 % directly
A ACENTA AS	Ordinære aksjer	7,446,547	900,644	4.93 % directly 4.93 % indirectly 19.23 %
X XQS HOLDING AS Closed		0	5,830,798	2 % indirectly
A AQUA BIO TECHNOLOGY ASA	NO0010307135	1,247,563	6,146,569	0.02 % directly < 0.01 %
I IMMUVERA THERAPEUTICS AS	Ordinære aksjer	220,410	15,816,725	0.02 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025